CA1277600C - Tumor therapeutic agent and a process for its preparation - Google Patents
Tumor therapeutic agent and a process for its preparationInfo
- Publication number
- CA1277600C CA1277600C CA000490026A CA490026A CA1277600C CA 1277600 C CA1277600 C CA 1277600C CA 000490026 A CA000490026 A CA 000490026A CA 490026 A CA490026 A CA 490026A CA 1277600 C CA1277600 C CA 1277600C
- Authority
- CA
- Canada
- Prior art keywords
- antigen
- molecular weight
- approximately
- therapeutic agent
- determinable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Peptides Or Proteins (AREA)
- Window Of Vehicle (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP3432714.2 | 1984-09-06 | ||
| DE19843432714 DE3432714A1 (de) | 1984-09-06 | 1984-09-06 | Tumortherapeutikum und verfahren zu seiner herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1277600C true CA1277600C (en) | 1990-12-11 |
Family
ID=6244749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000490026A Expired - Lifetime CA1277600C (en) | 1984-09-06 | 1985-09-05 | Tumor therapeutic agent and a process for its preparation |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0173951B1 (en:Method) |
| JP (1) | JPS6168427A (en:Method) |
| AT (1) | ATE64531T1 (en:Method) |
| CA (1) | CA1277600C (en:Method) |
| DE (2) | DE3432714A1 (en:Method) |
| DK (1) | DK172253B1 (en:Method) |
| ES (1) | ES8704082A1 (en:Method) |
| FI (1) | FI88360C (en:Method) |
| GR (1) | GR852149B (en:Method) |
| IE (1) | IE58638B1 (en:Method) |
| IL (1) | IL76289A (en:Method) |
| PT (1) | PT81093B (en:Method) |
| ZA (1) | ZA856807B (en:Method) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3806565A1 (de) * | 1988-03-01 | 1989-09-14 | Deutsches Krebsforsch | Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen |
| AT398900B (de) * | 1991-02-12 | 1995-02-27 | Pekar Rudolf Dr | Vakzine für eine immuntherapie |
| US6953668B1 (en) | 1992-11-05 | 2005-10-11 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
| DE69334071T2 (de) * | 1992-11-05 | 2007-10-25 | Sloan-Kettering Institute For Cancer Research | Prostata-spezifisches membranantigen |
| US7070782B1 (en) | 1992-11-05 | 2006-07-04 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
| US7105159B1 (en) | 1992-11-05 | 2006-09-12 | Sloan-Kettering Institute For Cancer Research | Antibodies to prostate-specific membrane antigen |
| US6569432B1 (en) | 1995-02-24 | 2003-05-27 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
| EP0812356B1 (en) | 1995-02-24 | 2006-02-08 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
| DE19506483A1 (de) * | 1995-02-24 | 1996-08-29 | Jens Dr Dr Atzpodien | Lyophilisat-Vakzine |
| US20050215472A1 (en) | 2001-10-23 | 2005-09-29 | Psma Development Company, Llc | PSMA formulations and uses thereof |
| EP1448588A4 (en) | 2001-10-23 | 2006-10-25 | Psma Dev Company L L C | ANTIBODIES AND MULTIMERS OF PSMA PROTEINS |
| CN1315536C (zh) * | 2002-09-13 | 2007-05-16 | 李进 | 肿瘤抗原疫苗及其制备方法和疫苗组合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4152410A (en) * | 1975-09-03 | 1979-05-01 | Eisai Co., Ltd. | Diagnosis reagent for neoplasm and method for diagnosis of neoplasm |
| DE2643215A1 (de) * | 1976-09-25 | 1978-04-06 | Bayer Ag | Cancerostatisch wirksame praeparationen aus tumorzellen und ein verfahren zu ihrer herstellung |
| ZA776822B (en) * | 1976-11-24 | 1979-06-27 | D Mccollester | Vaccine and method for immunotherapy of neoplastic disease |
| DE2918927A1 (de) * | 1979-05-10 | 1980-11-20 | Hans Prof Dr Limburg | Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung |
| US4446122A (en) * | 1979-12-28 | 1984-05-01 | Research Corporation | Purified human prostate antigen |
| US4468457A (en) * | 1981-06-01 | 1984-08-28 | David M. Goldenberg | Method for producing a CSAp tryptic peptide and anti-CSAp antibodies |
| DE3329184A1 (de) * | 1983-08-12 | 1985-02-21 | Behringwerke Ag, 3550 Marburg | Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene |
| DE3416774A1 (de) * | 1984-05-07 | 1985-11-14 | Behringwerke Ag, 3550 Marburg | Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung |
-
1984
- 1984-09-06 DE DE19843432714 patent/DE3432714A1/de not_active Withdrawn
-
1985
- 1985-08-27 DE DE8585110757T patent/DE3583265D1/de not_active Expired - Lifetime
- 1985-08-27 AT AT85110757T patent/ATE64531T1/de not_active IP Right Cessation
- 1985-08-27 EP EP85110757A patent/EP0173951B1/de not_active Expired - Lifetime
- 1985-09-03 DK DK402485A patent/DK172253B1/da not_active IP Right Cessation
- 1985-09-04 FI FI853389A patent/FI88360C/fi not_active IP Right Cessation
- 1985-09-04 ES ES546701A patent/ES8704082A1/es not_active Expired
- 1985-09-04 IL IL76289A patent/IL76289A/xx not_active IP Right Cessation
- 1985-09-04 GR GR852149A patent/GR852149B/el unknown
- 1985-09-05 CA CA000490026A patent/CA1277600C/en not_active Expired - Lifetime
- 1985-09-05 PT PT81093A patent/PT81093B/pt not_active IP Right Cessation
- 1985-09-05 IE IE219185A patent/IE58638B1/en not_active IP Right Cessation
- 1985-09-05 JP JP60195000A patent/JPS6168427A/ja active Pending
- 1985-09-05 ZA ZA856807A patent/ZA856807B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL76289A (en) | 1992-01-15 |
| EP0173951B1 (de) | 1991-06-19 |
| ES8704082A1 (es) | 1987-03-16 |
| DK402485A (da) | 1986-03-07 |
| ATE64531T1 (de) | 1991-07-15 |
| FI853389L (fi) | 1986-03-07 |
| EP0173951A3 (en) | 1988-06-08 |
| FI853389A0 (fi) | 1985-09-04 |
| FI88360B (fi) | 1993-01-29 |
| JPS6168427A (ja) | 1986-04-08 |
| ES546701A0 (es) | 1987-03-16 |
| IL76289A0 (en) | 1986-01-31 |
| EP0173951A2 (de) | 1986-03-12 |
| DK172253B1 (da) | 1998-02-09 |
| ZA856807B (en) | 1986-04-30 |
| DK402485D0 (da) | 1985-09-03 |
| FI88360C (fi) | 1993-05-10 |
| PT81093B (pt) | 1988-07-01 |
| DE3432714A1 (de) | 1986-04-24 |
| GR852149B (en:Method) | 1986-01-03 |
| PT81093A (de) | 1985-10-01 |
| IE852191L (en) | 1986-03-06 |
| DE3583265D1 (de) | 1991-07-25 |
| IE58638B1 (en) | 1993-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1277600C (en) | Tumor therapeutic agent and a process for its preparation | |
| JP2764019B2 (ja) | 免疫グロブリンeのためのリセプターに対するモノクローナル抗体 | |
| FI105452B (fi) | Idiotyyppirokotuksen valmistus B-solulymfoomaa vastaan | |
| JP3502125B2 (ja) | 形質転換細胞の抽出および培養ならびにそれらに対する抗体の製造 | |
| JP3429281B2 (ja) | 尿中関連抗原、抗原サブユニットの使用および検出方法 | |
| ES2211877T3 (es) | Linea celular linfoblastoide b humana que secreta un anticuerpo anti-gangliosido. | |
| EA006936B1 (ru) | Иммунотерапевтические комбинации для лечения опухолей, которые сверхэкспрессируют ганглиозиды | |
| CN118909107B (zh) | 抗p-Tau181抗体及其制备方法与应用 | |
| US5227160A (en) | Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen | |
| Nagy et al. | Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus | |
| JP2849683B2 (ja) | 「動物及びヒトのムチンを用い、並びに合成炭水化物−担体結合物を用いた免疫による、ヒト癌関連抗原に対するモノクローナル抗体」 | |
| RU2163243C2 (ru) | Белки из печени козы, обладающие противоопухолевой активностью, фармацевтическая композиция | |
| JPS59231026A (ja) | ヒト抗細胞巨大ウイルス・モノクロナ−ル抗体、これらの抗体を排出するハイブリド−マ及びヒト細胞巨大ウイルスの逐次的抗原決定基を有するポリペプチド | |
| Yoshiike et al. | Epidermolysis bullosa acquisita antigen: relationship between the collagenase-sensitive and-insensitive domains | |
| US20020192231A1 (en) | Method of increasing anti-neuGc antibody levels in blood | |
| JPS62501189A (ja) | 腫瘍↓−胎児に特異的なモノクロナ−ル抗体の調製方法および使用方法 | |
| CZ34293A3 (en) | Preparation for treating tumorous diseases | |
| US6294172B1 (en) | Monoclonal antibodies with specificity for membrane-associated antigens | |
| EP0381427A2 (en) | Vaccine Composition | |
| Berthier-Vergnes et al. | Induction of IgG Antibodies Directed to a M r 31,000 Melanoma Antigen in Patients Immunized with Vaccinia Virus Melanoma Oncolysates | |
| JPH05506241A (ja) | 35kd腫瘍関連タンパク質抗原および免疫複合体 | |
| EP4393947A1 (en) | Anti-pd-1 signal peptide antibody and use thereof | |
| Saya et al. | Derivation of a brain tumor-selective monoclonal antibody from hybridoma between mouse myeloma and rat spleen cells immune to syngeneic glioma | |
| Stavrou et al. | Chemical modification and antigenicity of glioma cells | |
| SU820015A1 (ru) | Способ получени вакцин против лейкоза крупного рогатого скота |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |